301326-22-7
Chemical Structure
CH-223191
- CAS No.: 301326-22-7
- Formula:C19H19N5O
- Molecular Weight:333.39
IUPAC Name: (E)-1-methyl-N-(2-methyl-4-(o-tolyldiazenyl)phenyl)-1H-pyrazole-5-carboxamide
InChIKey: LKTNEXPODAWWFM-GHVJWSGMSA-N
SMILES: O=C(C1=CC=NN1C)NC2=CC=C(/N=N/C3=CC=CC=C3C)C=C2C
Biological Activity: CH-223191 is a potent and specific antagonist of aryl hydrocarbon receptor (AhR). CH-223191 inhibits TCDD-mediated nuclear translocation and DNA binding of AhR, and inhibits TCDD-induced luciferase activity with an IC50 of 0.03 μM[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CH-223191 | 99.82% | CH-223191 is a potent and specific antagonist of aryl hydrocarbon receptor (AhR). CH-223191 inhibits TCDD-mediated nuclear translocation and DNA binding of AhR, and inhibits TCDD-induced luciferase activity with an IC50 of 0.03 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
CH-223191 (Standard) | ≥98% | CH-223191 (Standard) is the analytical standard of CH-223191 (HY-12684). This product is intended for research and analytical applications. CH-223191 is a potent and specific antagonist of aryl hydrocarbon receptor (AhR). CH-223191 inhibits TCDD-mediated nuclear translocation and DNA binding of AhR, and inhibits TCDD-induced luciferase activity with an IC50 of 0.03 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.73
HY-118780CHD-5 -
Similarity Score 0.60
HY-B2187Diacetazotol -
Similarity Score 0.59
HY-W040297R2-Methyl-5-(p-tolyldiazenyl)aniline (Standard) -
Similarity Score 0.57
HY-W328317Fast garnet GBC sulfate salt, 90% -
Similarity Score 0.54
HY-D0932RSudan IV (Standard) -
Similarity Score 0.54
HY-W112135N,N'-(2,5-Dimethyl-1,4-phenylene)diisonicotinamide -
Similarity Score 0.53
HY-120106BG14 -
Similarity Score 0.52
HY-W142459Naphthol AS-D -
Similarity Score 0.52
HY-105283RPF 04531083 (Standard) -
Explore the MedChemAI to find more analogs